Benzinga · Nov 11, 2026
TD Cowen Maintains Hold on P3 Health Partners, Lowers Price Target to $4
TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and lowers the price target from $13 to $4.
PI
NASDAQ · PIII
P3 Health Partners Inc.
Healthcare · Medical - Care Facilities
$2.70
Down-$0.05 (-1.82%)
Updated Nov 14, 2026, 2:29 AM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 17.06M
- P/E ratio
- -0.1
- Dividend yield
- 0.00%
- 52-week range
- $1.52 – $16.89
- Volume
- 29.47K
- Avg. volume
- 7.41K
Price performance · PIII
PIII price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
PIII closed at $2.70 after 21 trading sessions, down 34.78% for the selected period.
- Last close
- $2.70
- Period change
- -34.78%
- Period low
- $2.61
- Period high
- $4.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $2.77 | $2.81 | $2.51 | $2.70 | 29.47K |
| Nov 12, 2026 | $2.78 | $2.87 | $2.5086 | $2.75 | 46.36K |
| Nov 11, 2026 | $3.40 | $3.42 | $2.59 | $2.61 | 98.08K |
| Nov 10, 2026 | $4.31 | $4.5299 | $3.0106 | $3.38 | 750.66K |
| Nov 9, 2026 | $4.109 | $4.30 | $4.01 | $4.25 | 15.1K |
| Nov 6, 2026 | $3.97 | $4.10 | $3.97 | $4.00 | 7.33K |
| Nov 5, 2026 | $4.14 | $4.14 | $3.82 | $3.82 | 6.46K |
| Nov 4, 2026 | $3.99 | $4.20 | $3.99 | $4.10 | 11.7K |
| Nov 3, 2026 | $3.91 | $4.00 | $3.81 | $3.84 | 12.53K |
| Nov 2, 2026 | $3.98 | $4.16 | $3.79 | $3.9998 | 7.34K |
| Oct 30, 2026 | $4.20 | $4.355 | $3.8441 | $4.03 | 19.66K |
| Oct 29, 2026 | $4.07 | $5.24 | $4.07 | $4.20 | 49.9K |
| Oct 28, 2026 | $3.93 | $4.2499 | $3.91 | $4.03 | 12.24K |
| Oct 27, 2026 | $3.88 | $3.94 | $3.695 | $3.81 | 17.27K |
| Oct 26, 2026 | $4.20 | $4.20 | $3.88 | $3.88 | 6.5K |
| Oct 23, 2026 | $4.215 | $4.38 | $3.84 | $4.14 | 13.66K |
| Oct 22, 2026 | $4.30 | $4.43 | $4.15 | $4.36 | 11.31K |
| Oct 21, 2026 | $3.85 | $4.40 | $3.85 | $4.11 | 11.2K |
| Oct 20, 2026 | $3.88 | $4.27 | $3.88 | $3.97 | 9.53K |
| Oct 19, 2026 | $4.05 | $4.11 | $3.81 | $3.81 | 16.99K |
| Oct 16, 2026 | $4.20 | $4.32 | $4.10 | $4.14 | 15.25K |
Latest PIII news
The latest Smart Investors Daily articles mentioning PIII.
Stock researchCompany · Overview
Company
Market Activity
Research & News
PIII research
Overview
Company profile and research snapshot.
Company profile
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $12.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 11, 2026 | TD Cowen | Hold | — |
| May 22, 2026 | TD Cowen | Hold | — |
| May 15, 2026 | Lake Street | Buy | — |
| Apr 2, 2026 | TD Cowen | Hold | — |
| Mar 27, 2026 | Lake Street | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Nov 10, 2026
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers PepGen (NASDAQ:PEPG) stock rose 126.6% to $5.42 during Tuesday's regular session. The company's market cap stands at $165.5 million. The company's, Q3 earnings came out today. Nano X Imaging
Yahoo · Nov 10, 2026
P3 Health Partners Inc. Q3 2026 Earnings Call Summary
Moby summary of P3 Health Partners Inc.'s Q3 2026 earnings call
ChartMill · Nov 10, 2026
P3 Health Partners (NASDAQ:PIII) Q3 Revenue In Line as EPS Swings to Profit, Stock Slips After Hours
P3 Health Partners (PIII) Q3 revenue matched estimates, non-GAAP EPS beat, but mixed guidance and one-time benefits weighed on shares after hours.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
